Casper Sleep Inc (CSPR)

Common Stock

6.78  +0.48 (+7.62%)

Premarket: 6.71 -0.07 (-1.03%)

Fundamental Rating

1

Overall CSPR gets a fundamental rating of 1 out of 10. We evaluated CSPR against 68 industry peers in the Household Durables industry. CSPR has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CSPR is valued expensive at the moment.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CSPR has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -43.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -11.31%
PM (TTM) -16.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for CSPR has been increased compared to 1 year ago.
The debt/assets ratio for CSPR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.27, we must say that CSPR is in the distress zone and has some risk of bankruptcy.
CSPR has a Debt/Equity ratio of -1.18. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -1.18
Debt/FCF N/A
Altman-Z -1.27
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.87 indicates that CSPR may have some problems paying its short term obligations.
A Quick Ratio of 0.46 indicates that CSPR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.46

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.42% over the past year.
The Revenue has grown by 23.79% in the past year. This is a very strong growth!
Measured over the past years, CSPR shows a very strong growth in Revenue. The Revenue has been growing by 25.59% on average per year.
EPS 1Y (TTM)59.42%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-56.41%
Revenue 1Y (TTM)23.79%
Revenue growth 3Y25.59%
Revenue growth 5YN/A
Revenue growth Q2Q26.75%

3.2 Future

Based on estimates for the next years, CSPR will show a small growth in Earnings Per Share. The EPS will grow by 6.82% on average per year.
The Revenue is expected to grow by 16.02% on average over the next years. This is quite good.
EPS Next Y28.13%
EPS Next 2Y21.54%
EPS Next 3Y17.23%
EPS Next 5Y6.82%
Revenue Next Year24.47%
Revenue Next 2Y19.52%
Revenue Next 3Y17.78%
Revenue Next 5Y16.02%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSPR. In the last year negative earnings were reported.
Also next year CSPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.22

4.3 Compensation for Growth

A more expensive valuation may be justified as CSPR's earnings are expected to grow with 17.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y17.23%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Casper Sleep Inc

NYSE:CSPR (1/24/2022, 7:33:37 PM)

Premarket: 6.71 -0.07 (-1.03%)

6.78

+0.48 (+7.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap282.18M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.28%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -11.31%
PM (TTM) -16.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity -1.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.87
Quick Ratio 0.46
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)59.42%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)23.79%
Revenue growth 3Y25.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y